Guarded Optimism After Breast Cancer Drug Shows Promising Results
Sunday, April 6, 2014 - 20:10
in Health & Medicine
Palbociclib, a drug being developed by Pfizer, sharply cut the risk that advanced cancer would worsen among patients taking part in a Phase 2 study, researchers said.